PLASMID-INDUCED MECHANISMS OF ANTIBIOTIC RESISTANCE IN URINARY TRACT INFECTIONS
Abstract
In the present review considers the mechanisms of resistance induced by plasmids and associated with development of resistance genes
Downloads
References
Колесник М.О. Адаптована клінічна настанова з кращої практики діагностики, лікування та профілактики інфекцій сечової системи у жінок / М.О. Колесник, Н.М. Степанова, Л.О. Лебідь, [та ін.] // Український журнал нефрології та діалізу. - 2012. - №2 (34). - С. 53-77.
Колесник М.О. Медико-профілактична допомога хворим нефрологічного профілю в Україні / М.О. Колесник, Н.О. Сайдакова, Н.І. Козлюк «та ін.» // Український журнал нефрології та діалізу. - 2011. - №4(32). - С. 3-11.
Колесник М.О. Національний реєстр хворих на хронічну хворобу нирок 2010 / М.О. Колесник, Н.І. Козлюк, Г.С. Владзієвська, М.В. Кулизький // Державна установа «Інститут нефрології АМН України». - Київ. - 2011. - С. 10-22.
Boucher HW. Bad bugs, no drugs: no ESKAPE! An update from the Infectious Diseases Society ofAmerica / Boucher HW, Talbot GH, Bradley JS // Clin Infect Dis. - 2009. - №48. - P.1-12.
Carattoli A. Plasmids and the spread of resistance / A. Carattoli // Int J Med Microbiol. – 2013. – № 303(6-7). - P. 298-304.
Chong Y. Genetic evolution and clinical impact in extended-spectrum P-lactamase-producing Escherichia coli and Klebsiella pneumonia / Chong Y, Ito Y, Kamimura T // Infect Genet Evol. - 2011. - № 11(7). - P.1499-1504.
Curcio D. Multidrug-Resistant Gram-Negative Bacterial Infections: Are you Ready for the Challenge? / D.Curcio // Curr Clin Pharmacol. - 2013. - № 12. [Epub ahead of print].
Dalhoff A. Global Fluoroquinolone Resistance Epidemiology and Implictions for Clinical Use / A. Dalhoff // Interdisciplinary Perspectives on Infectious Diseases. - 2012. - № ID 976273. - P. 1-37.
D’Andrea MM. CTX-M-type P-lactamases: a successful story of antibiotic resistance / D’Andrea MM, Arena F, Pallecchi L [et al.] // Int J Med Microbiol. - 2013. - № 303(6-7). - P. 305-317.
Datta P. Epidemiology of Extended-Spectrum P-Lactamase, AmpC, and Carbapenemase Production in Proteus mirabilis / Datta P, Gupta V, Arora S [et al.] // Jpn J Infect Dis. - 2014. - № 67(1). - P. 44-46.
Denys GA. Antimicrobial susceptibility among gramnegative isolates collected in the USA between 2005 and 2011 as part of the Tigecycline Evaluation and Surveillance Trial (T.E.S.T.) / Denys GA, Callister SM, Dowzicky MJ // Ann Clin Microbiol Antimicrob. - 2013. - № 5. - P. 12-24.
Endimiani A. Bacteremia due to Klebsiella pneumoniae isolates producing the TEM-52 extended-spectrum P-lactamase: treatment outcome of patients receiving imipenem or ciprofloxacin / Endimiani A, Luzzaro F, Perilli M [et al.] // Clin Infect Dis. - 2004. - №38. - P. 243-251.
Gardiner BJ. Is fosfomycin a potential treatment alternative for multidrug-resistant gram-negative prostatitis? / Gardiner BJ, Mahony AA, Ellis AG[et al.] // Clin Infect Dis. - 2014. - № 58(4). - P. 101-105.
Gibold L. Four-year epidemiological study of extended-spectrum P-lactamase-producing Enterobacteriaceae in a French teach ing hospital / Gibold L, Robin F, Tan RN [et al.] // Clin Microbiol Infect. - 2014. - № 20(1). - P. 20-26.
Gupta K. Management of Urinary Tract Infections From Multidrug-Resistant Organisms / Gupta K, Bhadelia N // Infect Dis Clin North Am. - 2014. - № 28(1). - P. 49-59.
Huh K. Continuous increase of the antimicrobial resistance among gram-negative pathogens causing bacteremia: a nationwide surveillance study by the Korean Network for Study on Infectious Diseases (KONSID) / Huh K, Kim J, Cho SY [et al.] // Diagn Microbiol Infect Dis. - 2013. - № 76(4). - P. 477-482.
Kanj SS. Current concepts in antimicrobial therapy against resistant gram-negative organisms: extended-spectrum beta-lactamase-pro ducing Enterobacteriaceae, carbapenem-resis- tant Enterobacteriaceae, and multidrug-resistant Pseudomonas aeruginosa / Kanj SS, Kanafani ZA // Mayo Clin Proc. - 2011.- № 86(3). - P 250-259.
Kruse EB. Carbapenem-Resistant Enterobacteriaceae: Laboratory Detection and Infection Control Practices / Kruse EB, Aurbach U, Wisplinghoff H // Curr Infect Dis Rep. – 2013. – № 12. [Epub ahead of print].
Lee J. The impact of the increased use of piperacil- lin/tazobactam on the selection of antibiotic resistance among invasive Escherichia coli and Klebsiella pneumoniae isolates / Lee J, Oh CE, Choi EH // Int J Infect Dis. – 2013.- № 17(8). – P. 638-643.
Li W. Increasing Occurrence ofAntimicrobial-Resistant Hypervirulent (Hypermucoviscous) Klebsiella pneumoniae Isolates in China / Li W, Sun G, Yu Y [et al.] // Clin Infect Dis. – 2014. – № 58(2). – P. 225-232.
Lim CL. Evaluation of Ertapenem use with impact assessment on extended-spectrum beta-lactamases (ESBL) production and gram-negative resistance in Singapore General Hospital (SGH) / Lim CL, Lee W, Lee AL [et al.] // BMC Infect Dis. – 2013. – № 6. – P. 513-523.
Lopez-Cerero L. Comparative assessment of inoculum effects on the antimicrobial activity of amoxy- cillin-clavulanate and piperacillin-tazobactam with extended-spectrum beta-lactamase-producing and extended-spectrum beta-lactamase-non-producing Escherichia coli isolates / Löpez-Cerero L, Picon E, Morillo C [et al.] // Clin Microbiol Infect. – 2010. – № 16(2). – P. 132-136.
Macvane SH. Prolonging P-lactam infusion: A review of the rationale and evidence, and guidance for implementation / Macvane SH, Kuti JL, Nicolau DP // Int J Antimicrob Agents. – 2014. – № 43(2). – P.105-113.
Munoz-Price LS. Clinical epidemiology of the global expansion of Klebsiella pneumoniae carbapen- emases / Munoz-Price LS, Poirel L, Bonomo RA [et al.] // Lancet Infect Dis. – 2013. – № 13(9). – P. 785-796.
Page MG. Extended-spectrum P-lactamases: structure and kinetic mechanism / Page MG // Clin Microbiol Infect. – 2008. – № 14 (suppl 1). – P. 63-74.
Peterson LR. Antibiotic policy and prescribing strategies for therapy of extended-spectrum P-lactamase- producing Enterobacteriaceae: the role of pipera- cillin-tazobactam / Peterson LR // Clin Microbiol Infect. – 2008. – № 14 (suppl 1). – P. 181-184.
Pitout JD. Extended-spectrum P-lactamase- producing Enterobacteriaceae: an emerging public- health concern / Pitout JD, Laupland KB // Lancet Infect Dis. – 2008. – №8. – P. 159-166.
Pitout JD. Extraintestinal pathogenic Escherichia coli: an update on antimicrobial resistance, laboratory diagnosis and treatment / Pitout J // Expert Rev Anti Infect Ther. – 2012. – № 10(10). – P. 1165-1176.
Poirel L. Plasmid-mediated quinolone-resistance; interactions between human, animal and environmental ecologies / L. Poirel, V. Cattoir, P. Nordmann // Frontiers in Microbiology. - 2012. - №3(24). - P. 1-7.
Pontikis K. Outcomes of critically ill intensive care unit patients treated with fosfomycin for infections due to pandrug-resistant and extensively drug-resistant carbapenemase-producing Gram-negative bacteria / Pontikis K, Karaiskos I, Bastani S [et al.] // Int J Antimicrob Agents. - 2014. - № 43(1). - P. 52-59.
Rodriguez-Bano J. Community infections caused by extended-spectrum P-lactamase-producing Escherichia coli / Rodriguez-Bano J, Alcala JC, Cisneros JM [et al.] // Arch Intern Med. - 2008.- №168. - P.1897-1902.
Sanchez GV. In vitro antimicrobial resistance of urinary E. coli among U.S. outpatients from 2000 to 2010 / G.V. Sanchez, R.N. Master, J.A. Karlowsky // Antimicrob Agents Chemother. - 2012. - №56. - P. 2181-2183.
Schito G. C. The ARESC study: an international survey on the antimicrobial resistance of pathogens involved in uncomplicated urinary tract infections / G. C. Schito, K. G. Naber, H. Botto [et al.] // International Journal of Antimicrobial Agents. - 2009. - №5. - P. 407-413.
Schwaber MJ. An Ongoing National Intervention to Contain the Spread of Carbapenem-Resistant Enterobacteriaceae / Schwaber MJ, Carmeli Y // Clin Infect Dis. - 2014.- № 6. - P. 123-125.
Tan TY. CTX-M and AmpC Beta-lactamases Contributing to Increased Prevalence of Ceftriaxone-resistant Escherichia coli in Changi General Hospital, Singapore / Tan TY, Ng LS, He J [et al.] // Diagn Microbiol Infect Dis. – 2010. – №13(2). – Р. 210-213.
Tzouvelekis L.S. Carbapenemases in Klebsiella pneumoniae and Other Enterobacteriaceae: an Evolving Crisis of Global Dimensions / Tzouvelekis L.S., Markogiannakis A., Psichogiou M. // Clin Microbiol Rev. - 2012. - №25(4). - Р. 682-707.
Valenza G. Extended-Spectrum-ß-Lactamase- Producing Escherichia coli as Intestinal Colonizers in the German Community / Valenza G, Nickel S, Pfeifer Y // Antimicrob Agents Chemother. – 2014. – № 58(2). - Р. 1228-1230.
Veldman K. International collaborative study on the occurrence of plasmid-mediated quinolone resistance in Salmonella enterica and Escherichia coli isolated from animals, humans, food and the environment in 13 European countries / Veldman K, Cavaco LM, Mevius D [et al.] // J Antimicrob Chemother. - 2011.- № 66(6). - Р. 1278-1286.
Wailan AM. The spread and acquisition of NDM-1: a multifactorial problem / Wailan AM, Paterson DL // Expert Rev Anti Infect Ther. - 2014. - № 12(1). - Р. 91-115.
Wolska K. Resistance of Pseudomonas aeruginosa to antibiotics / Wolska K, Kot B, Piechota M [et al.] // Postepy Hig Med Dosw (Online). - 2013. - №16. - Р. 1300-1311.
